{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T21:15:43Z","timestamp":1761513343463,"version":"build-2065373602"},"reference-count":36,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2013,9,1]],"date-time":"2013-09-01T00:00:00Z","timestamp":1377993600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,9,1]],"date-time":"2013-09-01T00:00:00Z","timestamp":1377993600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Travel Medicine and Infectious Disease"],"published-print":{"date-parts":[[2013,9]]},"DOI":"10.1016\/j.tmaid.2013.08.007","type":"journal-article","created":{"date-parts":[[2013,9,5]],"date-time":"2013-09-05T15:00:44Z","timestamp":1378393244000},"page":"266-273","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"title":["Yellow fever vaccination: Is one dose always enough?"],"prefix":"10.1016","volume":"11","author":[{"given":"Dipti","family":"Patel","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hilary","family":"Simons","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.tmaid.2013.08.007_bib1","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1016\/S1473-3099(11)70147-5","article-title":"The revised global yellow\u00a0fever risk map and recommendations for vaccination, 2010: consensus of the informal WHO working group\u00a0on geographic risk for yellow fever","volume":"11","author":"Jentes","year":"2011","journal-title":"Lancet Infect Dis"},{"year":"2005","series-title":"International Health Regulations","author":"World Health Organization","key":"10.1016\/j.tmaid.2013.08.007_bib2"},{"key":"10.1016\/j.tmaid.2013.08.007_bib3","unstructured":"World Health Organization. Yellow fever vaccination requirements and recommendations. International Travel and Health. Available at: http:\/\/www.who.int\/ith\/chapters\/en\/index.html."},{"year":"2010","series-title":"Informal working group on geographic risk of yellow fever","author":"Background for the Consultation on Yellow Fever and International Travel","key":"10.1016\/j.tmaid.2013.08.007_bib4"},{"issue":"6","key":"10.1016\/j.tmaid.2013.08.007_bib5","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1093\/cid\/cis520","article-title":"Vaccine administration decision making: the case of yellow fever vaccine","volume":"55","author":"Lown","year":"2012","journal-title":"Clin Infect Dis"},{"issue":"5","key":"10.1016\/j.tmaid.2013.08.007_bib6","doi-asserted-by":"crossref","first-page":"954","DOI":"10.4269\/ajtmh.12-0463","article-title":"Travel characteristics and yellow fever vaccine usage among US Global TravEpiNet travelers visiting countries with risk of yellow fever virus transmission, 2009\u20132011","volume":"88","author":"Jentes","year":"2013","journal-title":"Am J Trop Med Hyg"},{"issue":"3","key":"10.1016\/j.tmaid.2013.08.007_bib7","doi-asserted-by":"crossref","first-page":"145","DOI":"10.2174\/157488611797579258","article-title":"Reporting rates of yellow fever 17D or 17DD \u2013 associated serious adverse events in pharmacovigilance databases: systematic review","volume":"6","author":"Thomas","year":"2011","journal-title":"Curr Drug Saf"},{"key":"10.1016\/j.tmaid.2013.08.007_bib8","series-title":"Vaccines","article-title":"Yellow fever vaccine","author":"Monath","year":"2013"},{"issue":"9276","key":"10.1016\/j.tmaid.2013.08.007_bib9","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/S0140-6736(01)05327-2","article-title":"Fever and multisystem organ failure associated with 17D-204 yellow fever vaccination: a report of four cases","volume":"358","author":"Martin","year":"2001","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.tmaid.2013.08.007_bib10","first-page":"741","article-title":"Case report: a case of yellow fever vaccine-associated viscerotropic disease in Ecuador","volume":"84","author":"Douce","year":"2010","journal-title":"Am J Trop Med Hyg"},{"issue":"43","key":"10.1016\/j.tmaid.2013.08.007_bib11","doi-asserted-by":"crossref","first-page":"5974","DOI":"10.1016\/j.vaccine.2009.07.082","article-title":"Viscerotropic disease following yellow fever vaccination in Peru","volume":"27","author":"Whittembury","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.tmaid.2013.08.007_bib12","unstructured":"World Health Organization. Background paper on yellow fever vaccine. SAGE Working Group. Available at: http:\/\/www.who.int\/immunization\/sage\/meetings\/2013\/april\/1_Background_Paper_Yellow_Fever_Vaccines.pdf."},{"key":"10.1016\/j.tmaid.2013.08.007_bib13","series-title":"Yellow fever vaccine","article-title":"Time of appearance and duration of immunity conferred by 17D vaccine","author":"Courtois","year":"1956"},{"key":"10.1016\/j.tmaid.2013.08.007_bib14","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1093\/oxfordjournals.aje.a121232","article-title":"Neutralizing antibody responses in the major immunoglobulin classes to yellow fever 17D vaccination of humans","volume":"93","author":"Monath","year":"1971","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.tmaid.2013.08.007_bib15","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1016\/S0264-410X(01)00457-1","article-title":"Clinical proof of principle for ChimeriVax: recombinant live, attenuated vaccines against flavivirus infections","volume":"20","author":"Monath","year":"2002","journal-title":"Vaccine"},{"issue":"5","key":"10.1016\/j.tmaid.2013.08.007_bib16","doi-asserted-by":"crossref","first-page":"533","DOI":"10.4269\/ajtmh.2002.66.533","article-title":"Comparative safety and immunogenicity of two yellow fever 17D vaccines (ARILVAX and YF-VAX) in a phase III, multicentre, double blind clinical trial","volume":"66","author":"Monath","year":"2002","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.tmaid.2013.08.007_bib17","doi-asserted-by":"crossref","first-page":"230","DOI":"10.4269\/ajtmh.1963.12.230","article-title":"Immunological studies with group B arthropod-borne viruses. IV. Persistence of yellow fever antibodies following vaccination with 17D strain yellow fever vaccine","volume":"12","author":"Rosenzweig","year":"1963","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.tmaid.2013.08.007_bib18","first-page":"895","article-title":"Persistence of neutralizing antibody 30\u201335 years after immunization with 17D yellow fever vaccine","volume":"59","author":"Poland","year":"1981","journal-title":"Bull World Health Organ"},{"key":"10.1016\/j.tmaid.2013.08.007_bib19","doi-asserted-by":"crossref","unstructured":"Gotuzzo E, C\u00f3rdova GR. Efficacy and duration of immunity following yellow fever vaccine: a systematic review on the need of yellow fever booster every 10 years. Available at: http:\/\/www.who.int\/immunization\/sage\/meetings\/2013\/april\/3_YF_BOOSTER_FINAL_DRAFT2.pdf.","DOI":"10.4269\/ajtmh.13-0264"},{"issue":"40","key":"10.1016\/j.tmaid.2013.08.007_bib20","first-page":"349","article-title":"Yellow fever vaccine. WHO position paper","volume":"78","author":"World Health Organization","year":"2003","journal-title":"Wkly Epidemiol Rec"},{"issue":"88","key":"10.1016\/j.tmaid.2013.08.007_bib21","first-page":"269","article-title":"Vaccines and vaccination against yellow fever. WHO position paper June 2013","volume":"27","author":"World Health Organization","year":"2013","journal-title":"Wkly Epidemiol Rec"},{"key":"10.1016\/j.tmaid.2013.08.007_bib22","article-title":"Yellow fever re-vaccination guidelines change \u2013 a decision too feverish?","author":"Grobulsh","year":"2013","journal-title":"Clin Microbiol\u00a0Infect"},{"issue":"6","key":"10.1016\/j.tmaid.2013.08.007_bib23","first-page":"391","article-title":"Quality improvement in travel medicine: a programme for yellow fever vaccination centres in England, Wales and Northern Ireland","volume":"19","author":"Boddington","year":"2011","journal-title":"Qual Prim Care"},{"issue":"4","key":"10.1016\/j.tmaid.2013.08.007_bib24","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/0035-9203(52)90062-X","article-title":"Immunity to yellow fever nine years after\u00a0vaccination","volume":"46","author":"Dick","year":"1952","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"10.1016\/j.tmaid.2013.08.007_bib25","first-page":"699","article-title":"Neutralizing and haemagglutination-inhibiting antibodies to yellow fever 17 years after vaccination with 17D vaccine","volume":"27","author":"Groot","year":"1962","journal-title":"Bull World Health Organ"},{"key":"10.1016\/j.tmaid.2013.08.007_bib26","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1002\/(SICI)1096-9071(199810)56:2<159::AID-JMV10>3.0.CO;2-B","article-title":"Development of viremia and humoral and cellular parameters of immune activation after vaccination with yellow fever virus strain 17D: a model of human flavivirus infection","volume":"56","author":"Reinhardt","year":"1998","journal-title":"J Med Virol"},{"key":"10.1016\/j.tmaid.2013.08.007_bib27","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1046\/j.1365-3156.1999.00496.x","article-title":"Assessment of IgG antibodies against yellow fever virus after vaccination with 17D by different assays: neutralization test, haemagglutination inhibition test, immunofluorescence assay and ELISA","volume":"4","author":"Niedrig","year":"1999","journal-title":"Trop Med Int Health"},{"key":"10.1016\/j.tmaid.2013.08.007_bib28","first-page":"796","article-title":"Yellow fever virus 17D neutralizing antibodies in vaccinated Colombian people and unvaccinated ones having immunity against dengue","volume":"10","author":"Gomez","year":"2008","journal-title":"Rev Salud Publica"},{"key":"10.1016\/j.tmaid.2013.08.007_bib29","doi-asserted-by":"crossref","first-page":"739","DOI":"10.4269\/ajtmh.2011.10-0496","article-title":"Description of a prospective 17DD yellow fever vaccine cohort in Recife, Brazil","volume":"85","author":"de Melo","year":"2011","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.tmaid.2013.08.007_bib30","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1007\/s13149-011-0135-7","article-title":"Persistance \u00e0 long terme des anticorps neutralisants de la fi\u00e8vre jaune chez les personnes \u00e2g\u00e9es de 60 ans et plus: long term persistance of yellow fever neutralising antibodies in elderly persons","volume":"104","author":"Bodilis","year":"2011","journal-title":"Bull Soc Pathol Exot"},{"year":"2012","series-title":"Epidemiology \u2013 an introduction","author":"Rothman","key":"10.1016\/j.tmaid.2013.08.007_bib31"},{"issue":"3","key":"10.1016\/j.tmaid.2013.08.007_bib32","doi-asserted-by":"crossref","first-page":"6327","DOI":"10.1016\/j.vaccine.2011.05.019","article-title":"Mutual interference on the immune response to yellow fever vaccine and a combined vaccine against measles mumps and rubella","volume":"29","author":"Nascimento Silva","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.tmaid.2013.08.007_bib33","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1586\/erv.12.6","article-title":"Review of the risks and benefits of yellow fever vaccination including some new analyses","volume":"4","author":"Monath","year":"2012","journal-title":"Expert Rev Vaccines"},{"issue":"RR-7","key":"10.1016\/j.tmaid.2013.08.007_bib34","article-title":"Yellow fever vaccine. Recommendations of the Advisory Committee on Immunisation Practices (ACIP)","volume":"59","author":"Centers for Disease Control and Prevention","year":"2010","journal-title":"Morbidity Mortality Weekly Rep"},{"issue":"15","key":"10.1016\/j.tmaid.2013.08.007_bib35","doi-asserted-by":"crossref","first-page":"2843","DOI":"10.1016\/j.vaccine.2005.12.055","article-title":"Neutralizing antibody response to booster vaccination with the 17d yellow fever vaccine","volume":"24","author":"Hepburn","year":"2006","journal-title":"Vaccine"},{"issue":"10","key":"10.1016\/j.tmaid.2013.08.007_bib36","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1111\/j.1468-1293.2008.00637.x","article-title":"British HIV association guidelines for immunization of HIV-infected adults 2008","volume":"9","author":"Geretti","year":"2008","journal-title":"HIV Med"}],"container-title":["Travel Medicine and Infectious Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1477893913001361?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1477893913001361?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T13:59:30Z","timestamp":1761487170000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1477893913001361"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,9]]},"references-count":36,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2013,9]]}},"alternative-id":["S1477893913001361"],"URL":"https:\/\/doi.org\/10.1016\/j.tmaid.2013.08.007","relation":{},"ISSN":["1477-8939"],"issn-type":[{"type":"print","value":"1477-8939"}],"subject":[],"published":{"date-parts":[[2013,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Yellow fever vaccination: Is one dose always enough?","name":"articletitle","label":"Article Title"},{"value":"Travel Medicine and Infectious Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tmaid.2013.08.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}